Nuformix PLC (NFX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.12p
Buy
0.14p
0.005p (+4.00%)
Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.
Prices updated at 09 May 2025, 16:10 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.14p - 0.12p | |
0.30p - 0.04p | |
- | |
2.12m | |
- | |
2,000,000 | |
20,438,005 | |
2.62 | |
29,972,820.17 | |
2.88 | |
819.31m | |
GB00BYW79Y38 | |
0.00 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.